Procter & Gamble Co
NYSE : PG$159.35+0.20%Oct 16 close
Financials
Consolidated Statements of Earnings
USD · reported units. Click a value to inspect its source.
| Reported line item | Jan 1, 2026 to Mar 31, 2026 (current) | Jul 1, 2025 to Mar 31, 2026 | Jan 1, 2025 to Mar 31, 2025 | Jul 1, 2024 to Mar 31, 2025 |
|---|---|---|---|---|
| Income Statement [Abstract] | ||||
| NET SALES | ||||
| Cost of products sold | ||||
| Selling, general and administrative expense | ||||
| OPERATING INCOME | ||||
| Interest expense | ||||
| Interest income | ||||
| Other non-operating income/(expense), net | ||||
| EARNINGS BEFORE INCOME TAXES | ||||
| Income taxes | ||||
| NET EARNINGS | ||||
| Less: Net earnings attributable to noncontrolling interests | ||||
| NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE | ||||
| NET EARNINGS PER COMMON SHARE | ||||
| Basic (in dollars per share)USD / share | ||||
| Diluted (in dollars per share)USD / share |
14 line items · 4 reported periodsOriginal filing order · parentheses indicate negative amounts
Each column reflects this filing’s presentation. Original line items and period dates are preserved.